A diagnosis of pre-eclampsia identifies women and babies who could benefit from close follow-up, medication (including that to lower blood pressure), and/or earlier birth. In 2019, […]
APEC are making the following statement regarding antenatal care and pre-eclampsia risk following the COVID19 pandemic. Pre-eclampsia • 1 in 30 women will develop pre-eclampsia during […]
Star of our 2020 Christmas campaign Khilna Shah, touched all our hearts when she shared her terrifying ordeal of sudden onset pre-eclampsia. We are delighted she […]
Each year the MBRRACE report ” Saving Lives, Improving Mothers’ Care” looks at maternal mortality in the previous trimester. It is extremely important in the UK […]
“amazing” “thought – provoking” “brilliant” Following the wonderful feedback from this years hugely successful day we have already got a note in our diaries for 2021 […]
The WILL trial aims to investigate the clinical effectiveness and cost-consequences of planned early term delivery at 38+0 to 38+3 weeks’ gestation, compared with expectant care at term […]
Low dose aspirin is now widely prescribed to women at risk of pre-eclampsia to reduce their risk of developing the disease. However, we know that some […]
Speakers included Kemi Badenoch MP and MBRRACE’s Prof Marian Knight. This year like so many other conferences and large meetings the annual expert meeting was held […]